IL141402A0 - Preventives/remedies for multiple organ failure - Google Patents
Preventives/remedies for multiple organ failureInfo
- Publication number
- IL141402A0 IL141402A0 IL14140299A IL14140299A IL141402A0 IL 141402 A0 IL141402 A0 IL 141402A0 IL 14140299 A IL14140299 A IL 14140299A IL 14140299 A IL14140299 A IL 14140299A IL 141402 A0 IL141402 A0 IL 141402A0
- Authority
- IL
- Israel
- Prior art keywords
- preventives
- remedies
- organ failure
- multiple organ
- failure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10249492A JP2000080046A (ja) | 1998-09-03 | 1998-09-03 | 多臓器障害の予防・治療剤 |
PCT/JP1999/004783 WO2000013707A1 (fr) | 1998-09-03 | 1999-09-03 | Medicaments preventifs/et remedes contre la defaillance de plusieurs organes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL141402A0 true IL141402A0 (en) | 2002-03-10 |
Family
ID=17193786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14140299A IL141402A0 (en) | 1998-09-03 | 1999-09-03 | Preventives/remedies for multiple organ failure |
Country Status (12)
Country | Link |
---|---|
US (1) | US6596754B1 (no) |
EP (1) | EP1110556A4 (no) |
JP (1) | JP2000080046A (no) |
KR (1) | KR20010099628A (no) |
CN (1) | CN1315873A (no) |
AU (1) | AU5448699A (no) |
CA (1) | CA2342796A1 (no) |
ID (1) | ID28693A (no) |
IL (1) | IL141402A0 (no) |
NO (1) | NO20011096L (no) |
TW (1) | TW533074B (no) |
WO (1) | WO2000013707A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7579325B2 (en) | 2001-03-21 | 2009-08-25 | Eisai R & D Management Co., Ltd. | Drugs containing reduced of vitamin B2 |
AU2003284596A1 (en) * | 2002-11-22 | 2004-06-18 | Takeda Pharmaceutical Company Limited | Imidazole derivative, process for producing the same, and use |
AU2003302238A1 (en) | 2002-12-03 | 2004-06-23 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
CA2610157A1 (en) * | 2005-06-09 | 2006-12-21 | Bristol-Myers Squibb Company | Methods of identifying and treating individuals exhibiting mutant kit protein |
US10646313B2 (en) | 2016-10-12 | 2020-05-12 | Solmetex, L.L.C. | Dental amalgam separation and recycling system |
AU2018253392B2 (en) | 2017-04-14 | 2023-11-02 | Capsugel Belgium Nv | Process for making pullulan |
JP2020516653A (ja) | 2017-04-14 | 2020-06-11 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップCapsugel Belgium NV | プルランカプセル |
WO2019241213A1 (en) * | 2018-06-11 | 2019-12-19 | The Regents Of The University Of Colorado, A Body Corporate | 2-naphthimidamides, analogues thereof, and methods of treatment using same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5466668A (en) * | 1989-04-28 | 1995-11-14 | Schering Aktiengesellschaft | Superior thrombomodulin analogs for pharmaceutical use |
US5252725A (en) * | 1989-06-23 | 1993-10-12 | The Trustees Of The University Of Pennsylvania | α-1-antichymotrypsin, analogues and methods of production |
IL101062A0 (en) * | 1991-02-28 | 1992-11-15 | Erba Carlo Spa | Anti-thrombin polypeptides and their preparation |
ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
JP3388803B2 (ja) * | 1993-05-20 | 2003-03-24 | 第一製薬株式会社 | 光学活性7−アミジノナフタレン誘導体の製造法 |
-
1998
- 1998-09-03 JP JP10249492A patent/JP2000080046A/ja active Pending
-
1999
- 1999-09-03 ID IDW20010522A patent/ID28693A/id unknown
- 1999-09-03 US US09/786,236 patent/US6596754B1/en not_active Expired - Fee Related
- 1999-09-03 TW TW088115221A patent/TW533074B/zh not_active IP Right Cessation
- 1999-09-03 CA CA002342796A patent/CA2342796A1/en not_active Abandoned
- 1999-09-03 IL IL14140299A patent/IL141402A0/xx unknown
- 1999-09-03 AU AU54486/99A patent/AU5448699A/en not_active Abandoned
- 1999-09-03 KR KR1020017002214A patent/KR20010099628A/ko not_active Application Discontinuation
- 1999-09-03 EP EP99940643A patent/EP1110556A4/en not_active Withdrawn
- 1999-09-03 CN CN99810429A patent/CN1315873A/zh active Pending
- 1999-09-03 WO PCT/JP1999/004783 patent/WO2000013707A1/ja not_active Application Discontinuation
-
2001
- 2001-03-02 NO NO20011096A patent/NO20011096L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1315873A (zh) | 2001-10-03 |
CA2342796A1 (en) | 2000-03-16 |
EP1110556A1 (en) | 2001-06-27 |
JP2000080046A (ja) | 2000-03-21 |
AU5448699A (en) | 2000-03-27 |
TW533074B (en) | 2003-05-21 |
KR20010099628A (ko) | 2001-11-09 |
NO20011096D0 (no) | 2001-03-02 |
US6596754B1 (en) | 2003-07-22 |
ID28693A (id) | 2001-06-28 |
NO20011096L (no) | 2001-03-02 |
WO2000013707A1 (fr) | 2000-03-16 |
EP1110556A4 (en) | 2004-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69922944D1 (en) | Lichtquelle für photodynamische therapie | |
GB9825651D0 (en) | Actuator | |
AU3898999A (en) | Aloe pectins | |
AU138616S (en) | Humidifier | |
AU5647099A (en) | Remedal or preventive agent for congestive heart failure | |
EP1053749A4 (en) | PREVENTION AND MEDICINE FOR NEURODEGENERATIVE DISEASES | |
HUP9901642A3 (en) | Remedies or preventives for aids | |
IL141402A0 (en) | Preventives/remedies for multiple organ failure | |
AU3987800A (en) | Preventives/remedies for angiostenosis | |
GB2344402B (en) | Actuator | |
IL142557A0 (en) | Remedies for bone metabolic errors | |
GB9810529D0 (en) | Intumescent composition | |
EP1055429A4 (en) | NEW PREVENTION MEDICINE / MEDICINE FOR IMMUNOPATHIES | |
EP1297839A4 (en) | THERAPEUTIC AND PROPHYLACTIC AGENTS FOR CARDIAC INSUFFICIENCY | |
IL140674A0 (en) | Remedies or preventives for intractable epilepsy | |
EP1157697A4 (en) | REMEDIES FOR HYPERAMMONIA | |
EP1057491A4 (en) | PREVENTIVE MEANS / REMEDIES AGAINST SKIN AGING | |
GB2334675B (en) | Improved intumescent ventilator | |
HK1021261A1 (en) | Joint box. | |
GB9823389D0 (en) | Humidifiers | |
HK1041643A1 (en) | Preventives for hepatopathy. | |
AU6006099A (en) | Preventives or remedies for cachexia | |
EP1061636A4 (en) | ACTUATOR | |
EP0983763A4 (en) | MEDICINES AGAINST RECONSTRICTION | |
EP0976400A4 (en) | PREVENTIVE MEASURES AND REMEDY FOR KIDNEY DISEASE |